Company intelligence / Profile preview

Liof Pharma

Miñano Mayor, Álava, Spain

Ownership: Private
Development stage: Commercial

Overview

Liof Pharma is an active European biotech CDMO specializing in aseptic fill-finish and lyophilization of sterile drugs (including biologics such as peptides, proteins, antibodies/mAbs, RNA products), with GMP certification and experience supporting clinical through commercial supply. They have passed FDA preapproval inspection and serve global markets[1][2][3][4][5].

Modalities: Small moleculeBiologicAntibodyAntibody-drug conjugateRecombinant proteinmRNA-based drugs (mRNA vaccine)Protein vaccineViral vector vaccine
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Liof Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liof Pharma.

Explore the full profile